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PAging Mouse Hearts Are Refractory to
Infarct Size Reduction With Post-Conditioning
Karin Przyklenk, PHD,*†‡ Michelle Maynard,* Chad E. Darling, MD,* Peter Whittaker, PHD*†‡§
Worcester, Massachusetts; and Detroit, Michigan
Objectives Our aim was to establish whether the efficacy of post-conditioning is maintained in aging hearts.
Background Post-conditioning, or relief of myocardial ischemia in a stuttered manner, has been shown to reduce infarct size, in
part because of up-regulation of survival kinases (extracellular-signal regulated kinase [ERK] 1/2 or PI3-kinase/Akt)
during the early min of reperfusion. All of these data have, however, been obtained in adult populations; the question
of whether post-conditioning–induced cardioprotection is maintained in aging cohorts is unknown.
Methods Isolated buffer-perfused hearts were obtained from 3- to 4-month-old (adult) and 20- to 24-month-old C57BL/6J
mice and subjected to 30 min of ischemia. For each cohort, hearts were randomized to receive standard, abrupt
(control) reperfusion, or were post-conditioned with 3 or 6 10-s cycles of stuttered reflow. Primary end points
were infarct size, cardiac expression of phospho-Akt, phospho-mitogen-activated protein kinase kinase 1/2 and
phospho-ERK 1/2, and expression of mitogen-activated protein kinase-phosphatase-1 (MKP-1: phosphatase pur-
ported to play a primary role in ERK dephosphorylation).
Results In adult mouse hearts, post-conditioning significantly reduced infarct size via up-regulation of ERK (but not Akt)
signaling. In contrast, in the 2-year-old cohort, post-conditioning failed to limit necrosis, possibly a consequence
of the deficit in ERK phosphorylation and increased MKP-1 expression seen in old hearts. Indeed, infusion of so-
dium orthovanadate, a nonspecific MKP inhibitor, attenuated MKP-1 expression and restored the post-
conditioned phenotype in old hearts.
Conclusions Old mouse hearts are refractory to infarct size reduction with post-conditioning, possibly because of an age-
associated increase in MKP-1 and resultant deficit in ERK phosphorylation. (J Am Coll Cardiol 2008;51:
1393–8) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.11.070f
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smerging evidence has revealed that post-conditioning, or
elief of sustained myocardial ischemia in a stuttered man-
er, attenuates lethal myocardial ischemia-reperfusion injury
nd significantly reduces infarct size (1–5). Moreover, although
he mechanisms contributing to post-conditioning–induced
ardioprotection are as yet poorly understood, activation of
xtracellular-signal regulated kinase (ERK) 1/2 and/or
hosphatidylinositol-3-kinase (PI3-kinase) during the early
in after relief of ischemia has been implicated to play a pivotal
ole (2,6–8). Virtually all of these data have, however, been
btained in adult populations: with the exception of one recent
eport (9), there is currently no insight into whether the
nfarct-sparing effect of stuttered reflow is maintained in hearts
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ichigan. Supported in part by National Institutes of Health grant R01-HL63713
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007, accepted November 19, 2007.rom aging cohorts, a subset of particular relevance for the
uture clinical application of post-conditioning (10). To ad-
ress this issue, we investigated the efficacy of infarct size
eduction with post-conditioning in adult and 2-year-old mice.
See page 1399
e report that in adult mouse hearts, post-conditioning
vokes a robust reduction of infarct size that is mediated by
p-regulation of ERK 1/2. In contrast, hearts from 2-year-old
ice are refractory to post-conditioning–induced cardioprotec-
ion, possibly because of a deficit in ERK phosphorylation.
ethods
his study was approved by the Institutional Animal
are and Use Committee of the University of Massachu-
etts Medical School, and was performed in accordance
ith the Guide for the Care and Use of Laboratory
nimals from the Institute of Laboratory Animals Re-
ources (National Institutes of Health Publication Vol. 25
o. 28, revised 1996).
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Post-Conditioning and Aging April 8, 2008:1393–8Protocol 1:
Post-Conditioning in Adult Mice
Infarct size. Infarct size was as-
sessed in isolated buffer-perfused
mouse hearts using standard
methods described previously (11).
In brief, adult (3- to 4-month-old)
C57BL/6J mice (n  44) were
anesthetized with sodium pento-
barbital (60 mg/kg intraperitone-
ally), and the hearts were rapidly
excised and mounted on an aortic
cannula for retrograde perfusion
(nonrecirculating) at a constant
pressure of 55 mm Hg. The buffer
was composed of (in mM): NaCl
(118), KCl (4.7), NaHCO3 (24),
KH2PO4 (1.2), MgSO4-7H2O
1.2), glucose (11), and CaCl2 anhydrous (2.5) in distilled
ater at a pH of 7.4, and was continuously oxygenated with
5% O2/5% CO2. Care was taken to maintain both buffer
emperature and heart temperature at 37°C. A balloon con-
tructed of polyvinyl chloride plastic film was inserted into the
eft ventricle (LV), inflated to an end-diastolic pressure of 5
m Hg, and used to monitor cardiodynamic function
hroughout the experiment.
After stabilization, all hearts underwent 30 min of sustained
lobal ischemia. The first 34 hearts enrolled in the protocol
ere randomly assigned to undergo: 1) abrupt and complete
eperfusion (control subjects); 2) post-conditioning with 3
ycles of [10 s reperfusion  10 s reocclusion] followed by
ustained restoration of flow; or 3) post-conditioning with 6
ycles of [10 s reflow  10 s reocclusion] followed by
ustained reperfusion. The remaining 10 hearts all received
n infusion of PD98059 (5 M final concentration), initi-
ted at the time of reperfusion and administered via a side
ort immediately proximal to the heart. This dose of
D98059 was confirmed, in separate experiments in our
aboratory, to inhibit up-regulation of mitogen-activated
rotein kinase kinase (MEK) and ERK (data not shown).
he PD98059-treated hearts then underwent either abrupt
control) reperfusion or post-conditioning with 3 10-s cycles
f stuttered reflow, with infusion of the inhibitor main-
ained for a total of 20 min.
At 2 h after the onset of reperfusion, each heart was cut into
to 6 transverse slices and the extent of necrosis was delineated
y triphenyltetrazolium staining. All hearts were digitally
hotographed, and infarct size was quantified in a blinded
anner (without knowledge of the treatment group) using
mage analysis software (11).
mmunoblotting. Buffer-perfused hearts were obtained
rom additional adult C57 mice (n  12) as described for
he infarct size protocol and assigned to undergo 30 min of
lobal ischemia followed by abrupt, complete reperfusion
Abbreviations
and Acronyms
ANOVA  analysis of
variance
ERK  extracellular-signal
regulated kinase
LV  left ventricle/
ventricular
MEK  mitogen-activated
protein kinase kinase
MKP  mitogen-activated
protein kinase phosphatase
PI3 kinase 
phosphatidylinositol-3-kinase
STAT3  signal transducer
and activator of
transcription 3control subjects), 30 min of ischemia followed by 3 10-s pycles of stuttered reflow (post-conditioned), or time-
atched uninterrupted perfusion (nonischemic shams). At
0 min after reflow, all hearts were frozen in liquid nitrogen
nd stored at 80°C until processed.
Hearts were prepared, and using methods described in
etail previously (2,11), were probed by standard immuno-
lotting for the expression of phospho-Akt, MEK 1/2, and
RK 1/2, then stripped and re-probed for the expression of
otal Akt, MEK 1/2, and ERK 1/2 (all antibodies from Cell
ignaling Technology, Danvers, Massachusetts). Bands of
nterest were quantified without knowledge of the group
ssignment using gel analysis software, and results for
hospho-Akt, MEK, and ERK were normalized to the
orresponding total kinase expression.
rotocol 2: Post-Conditioning in Old Mice
nfarct size. Hearts were isolated from 20- to 24-month-
ld C57BL/6J mice (n 34) and buffer-perfused as detailed
n Protocol 1. All hearts underwent 30 min of global
schemia and received either control (abrupt) reflow or
ost-conditioning with 3 or 6 10-s cycles of reperfusion-
eocclusion. Infarct size was delineated and quantified as in
rotocol 1.
mmunoblotting. Hearts from 20- to 24-month-old C57
ice (n  12) were assigned to sham, control, and 3-cycle
ost-conditioning groups, and frozen at 10 min after relief
f ischemia for immunoblot analysis of Akt, MEK, and
RK using the same methods described in Protocol 1.
rotocol 3: Post-Conditioning in Old Mice; Role of
itogen-Activated Protein Kinase Phosphatases (MKPs)
ased on the outcomes of Protocols 1 and 2, supplemental
xperiments were conducted to investigate the concept of a
ossible causal relationship between failed up-regulation of
RK and loss of post-conditioning–induced cardioprotec-
ion in aging mouse hearts. First, because negative regula-
ion of ERK is controlled primarily by members of the
KP family (12–15), tissue from adult and old hearts
ollected in Protocols 1 and 2 was probed by immunoblot-
ing for the expression of MKP-1, MKP-3 (antibodies from
anta Cruz Biotechnology, Santa Cruz, California) and, for
urposes of normalization, -actin (Cell Signaling Tech-
ology). Second, additional hearts (n  20) were harvested
rom 2-year-old mice and infused with sodium orthovana-
ate, a nonspecific inhibitor of MKPs (16,17) (final con-
entration in buffer, 2 M). At 45 min after the start of
reatment, hearts underwent 30 min of global ischemia
ollowed by either abrupt reflow or 3 10-s cycles of post-
onditioning, with infusion of vanadate maintained
hroughout the first 10 min of reperfusion. In 12 hearts,
eperfusion was continued for 2 h and infarct size was
elineated by triphenyltetrazolium staining. The remaining
anadate-treated hearts (4 control subjects, 4 post-
onditioned) were frozen at 10 min post-reflow and pro-
essed for immunoblot analysis of MKPs, -actin,
hospho-ERK, and total ERK.
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April 8, 2008:1393–8 Post-Conditioning and Agingtatistics. Because Protocols 1, 2, and 3 were conducted
onsecutively rather than concurrently, separate statistical
nalyses were performed for each component of the study.
or Protocols 1 and 2, infarct size (expressed as a percent of
otal LV weight) and kinase expression were compared
mong groups by analysis of variance (ANOVA) and, if
ignificant F-values were obtained, post-hoc pairwise com-
arisons were made using the Newman-Keuls test. For
rotocol 3, MKP expression (normalized to -actin) was
ompared among adult hearts, old hearts, and old hearts
nfused with sodium vanadate by ANOVA followed by the
ewman-Keuls test, whereas infarct size and ERK expres-
ion were compared between vanadate-treated control and
ost-conditioned groups by t test. All data are reported as
ean  SEM.
esults
rotocol 1
n adult hearts, infarct size averaged 53  5%, 27  3%*,
nd 29  5%* of the total LV in hearts that received abrupt
control) reperfusion, post-conditioning with 3 10-s cycles
f stuttered reflow and post-conditioning with 6 10-s cycles
f interrupted reflow, respectively (Fig. 1A). (*p  0.05 vs.
ontrol). That is, post-conditioning was cardioprotective, with
o difference in benefit seen with 3 versus 6 episodes of
eperfusion-reocclusion.
There were no differences in total Akt, MEK, or ERK
mong sham, control, and post-conditioned groups (data
ot shown). Hearts that received stuttered reflow showed an
pproximate 2-fold increase in expression of both phospho-
EK and phospho-ERK versus control subjects, whereas
hospho-Akt was not up-regulated in response to post-
onditioning (Fig. 1B). These data, implicating the involve-
ent of MEK-ERK signaling in post-conditioning–
nduced protection, were corroborated in infarct size
xperiments showing that the infarct-sparing effect of post-
onditioning was abrogated by co-administration of
D98059 (Fig. 1A).
rotocol 2
n contrast to results obtained in the adult cohort, post-
onditioning failed to limit necrosis in hearts from 2-year-
ld mice: infarct sizes averaged 43 3%, 40 4%, and 41 
% of the total LV in control, 3-cycle post-conditioning,
nd 6-cycle post-conditioning groups (Fig. 2A). Moreover,
here was no evidence of an up-regulation of phospho-ERK
or phospho-Akt) in response to stuttered reflow; expression
f phospho-ERK was attenuated, rather than augmented, in
ost-conditioned hearts versus both sham and control
roups (p  0.065 by ANOVA) (Fig. 2B). Paradoxically,
his deficit in ERK phosphorylation was seen despite a
ersistent, post-conditioning–induced increase in expres-
ion of phospho-MEK in old mouse hearts (Fig. 2B). orotocol 3
ardiac expression of MKP-1 was augmented in hearts from
Figure 1 Protocol 1, Adult Mouse Hearts
(A) Infarct size (expressed as a percent of the total left ventricle [LV]).
(B) Expression of phospho-Akt, phospho-MEK 1/2, and phospho-ERK 1/2.
Data shown as mean  SEM. ERK  extracellular-signal regulated kinase;
MEK  mitogen-activated protein kinase kinase; PostC  post-conditioned; PD
 PD98059. *p  0.05 versus sham. †p  0.05 versus control. ‡p  0.07
versus control.ld mice versus adults (Fig. 3A), irrespective of the treatment
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Post-Conditioning and Aging April 8, 2008:1393–8roup (i.e., no differences among sham, control, and post-
onditioned groups within each of the 2 cohorts). In contrast,
xpression of MKP-3 was comparable in hearts obtained from
ld and adult mice (data not shown). Infusion of sodium
rthovanadate blunted the increase in MKP-1 expression seen
n old hearts (Fig. 3A) and tended to re-establish the ability of
tuttered reflow to evoke an increase in phospho-ERK (Fig.
Figure 2 Protocol 2, Old Mouse Hearts
(A) Infarct size (expressed as a percent of the total left ventricle [LV]).
(B) Expression of phospho-Akt, phospho-MEK 1/2, and phospho-ERK 1/2.
Data shown as mean  SEM. *p  0.05 versus sham. †p  0.05 versus con-
trol. Abbreviations as in Figure 1.B). In addition, a modest but significant difference in infarctize was seen in orthovanadate-treated old post-conditioned
earts versus old control subjects (Fig. 3C).
iscussion
e report that post-conditioning reduces infarct size in adult
ouse hearts, mediated in part via MEK-ERK signaling.
ost notably, however, we provide evidence for a loss in
fficacy of post-conditioning in hearts from 2-year-old mice.
ost-Conditioning in Adult Cohorts
ur observation of infarct size reduction with post-
onditioning in hearts from adult C57BL/6J mice is consistent
ith the emerging paradigm of post-conditioning–induced
ardioprotection described in multiple species including, most
ecently, a small number of studies conducted in mouse models
Figure 3 Protocol 3, Role of MKPs
(A) Expression of MKP-1 in adult mouse hearts, 2-year-old mouse hearts, and
2-year-old mouse hearts infused with sodium orthovanadate (NaV). *p  0.05
versus adult. (B) Expression of phospho-ERK 1/2 in 2-year-old mouse hearts
infused with NaV. ‡p  0.08 versus NaV  control. (C) Infarct size (expressed
as a percent of the total left ventricle [LV]) in 2-year-old mouse hearts infused
with NaV. *p  0.05 versus NaV  control. All data shown as mean  SEM.
Abbreviations as in Figure 1.
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April 8, 2008:1393–8 Post-Conditioning and Aging4,5,9). There is growing evidence that the efficacy of the
nfarct-sparing effect of stuttered reflow is dependent on both
umber and duration of the constituent ischemia-reperfusion
ycles, and that the optimal post-conditioning algorithm may
ary among models and species (3,4,9,18,19). In this regard,
ur choice of 10-s cycles of stuttered reflow was based on pilot
tudies in which we found that repeated 30-s episodes of
schemia-reperfusion, shown to reduce infarct size in rabbit
earts (2), were ineffective in isolated mouse hearts. In terms of
ellular mechanisms, there is general agreement that the
nfarct-sparing effect of post-conditioning is in part attributable
o up-regulation of the classic survival kinases (ERK 1/2 and/or
I3 kinase/Akt) during the early minutes after stuttered reflow
2,6–8). We found no evidence of up-regulation of Akt in
ost-conditioned hearts versus control subjects, either at 10
in post-reflow (Fig. 1) or at earlier time points (data not
hown), and in supplemental experiments, saw persistent
nfarct size reduction with post-conditioning in hearts infused
ith the PI3 kinase inhibitor LY294002 (mean infarct size of
2 4% versus 51 2% in inhibitor-treated control subjects;
 0.05). In contrast, we did observe an increase in expression
f phospho-MEK and phospho-ERK in response to stuttered
eflow, and abrogation of post-conditioning–induced protec-
ion in hearts treated with PD98059. Thus, although the
emporal profile of the up-regulation of MEK and ERK
emains to be established, the current results support the
nvolvement of MEK-ERK signaling in the infarct-sparing
ffect of post-conditioning in the mouse model.
We have focused on the assessment of infarct size rather
han indices of LV function (i.e., acute recovery of LV
eveloped pressure) as our primary end point of post-
onditioning–induced cardioprotection. This is based on
revious observations by our group and others that reduc-
ion of infarct size with post-conditioning is not accompa-
ied by a significant improvement in LV cardiodynamics
uring the initial hours after relief of ischemia (2,4,7). The
ack of improvement in function in post-conditioned hearts
ersus control subjects may reflect 2 related factors. First,
lobal LV function measured in these models represents an
ntegrated assessment of the contribution of the akinetic-
yskinetic necrotic region and the viable and salvaged but
rofoundly stunned (hypokinetic-akinetic-dyskinetic) peri-
nfarct tissue. Second, although stuttered reflow reduces
nfarct size, these initial studies suggest that post-
onditioning does not have an independent, sustained ben-
ficial effect on the acute recovery of function of post-
schemic stunned myocardium. Indeed, similar results were
btained in the current study: LV function recovered to 30%
o 40% of baseline values during the reperfusion period, with
o differences among control and post-conditioning groups.
oss of Post-Conditioning–Induced
ardioprotection in Aging Mouse Hearts
espite the consensus that relief of ischemia in a stuttered
anner can limit infarct size in experimental models andecent, seminal evidence that post-conditioning may be of elinical benefit (20,21), the question of whether post-
onditioning–induced cardioprotection is maintained in ag-
ng cohorts has to date received limited attention (9). This
ssue is crucial for future widespread therapeutic application
f post-conditioning because the aging population is well
ecognized to be the specific subset in which acute myocar-
ial infarction is most prevalent (10).
Accordingly, to assess the consequences of increased age
n the efficacy of post-conditioning, we utilized 2-year-old
ice, considered a standard model of aging (22–24) and
onfirmed in pilot experiments by our group to display
lassic morphologic and molecular features of cardiovascular
ging and senescence (i.e., hypertrophy, increased fibrosis,
nd increased myocardial expression of p16INK4a (25,26)
ersus 3- to 4-month-old mice, data not shown). Comparison of
rotocols 1 and 2 indicates that in control mouse hearts there was
o age-associated exacerbation of infarct size. Rather, post-hoc
nalysis by 2-factor ANOVA (for age and treatment) indicates
hat infarct size was smaller in old-control versus adult-control
ohorts (p  0.05), in agreement with previous studies showing
hat the extent of necrosis was modestly reduced, or comparable,
n aging cohorts versus adults (26–28). Most importantly, data
btained in Protocol 2 showed that in aging mouse hearts,
ost-conditioning failed to evoke an increase in expression of
hospho-ERK and was ineffective in reducing infarct size. This
oncept of an age-associated loss in efficacy of infarct size reduc-
ion with post-conditioning was reinforced by the outcome of our
ost-hoc 2-factor ANOVA, i.e., p  0.022 for the age 
reatment interaction. Moreover, our findings made in hearts from
-year-old mice showing definitive hallmarks of cardiovascular
ging extend the recent observation of an attenuation (rather than
omplete loss) of the infarct-sparing effect of post-conditioning in
ice of an intermediate, 13-month-old age (9).
ole of MKPs
f, as identified in Protocol 1, up-regulation of ERK plays a
ole in the infarct-sparing effect of post-conditioning, we
easoned that the loss-of-benefit of post-conditioning in old
ouse hearts may in part be attributable to the observed
eficit in ERK phosphorylation. Failed up-regulation of
RK in old post-conditioned hearts could be a consequence
f a defect in upstream signaling; however, the persistent
ncrease in phospho-MEK seen with stuttered reflow in the
ging cohort argues against this concept. Accordingly, our
oal in Protocol 3 was to investigate the logical, alternative
ossibility: that is, obtain preliminary insight into whether
he loss of post-conditioning–induced protection is explained
y an age-associated increase in ERK dephosphorylation.
Although negative regulation of ERK is a complex
rocess that can be achieved by tyrosine-specific protein
hosphatases, serine/threonine protein phosphatase, and/or
ual-specificity phosphatases that dephosphorylate both
yrosine and threonine, members of the dual-specificity
KP family, including MKP-1 and -3, purportedly play a
rimary role in ERK dephosphorylation (12–15). Our
xperiments in Protocol 3 are among the few studies that
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Post-Conditioning and Aging April 8, 2008:1393–8ave assessed MKPs in the heart (13,29,30), and show a
ignificant increase in cardiac expression of MKP-1 in
-year-old mice versus adults. Moreover, we found that
nfusion of sodium orthovanadate both attenuated the
ncrease in MKP-1 expression and restored the post-
onditioned phenotype in the aging cohort. Given the
onspecific actions of orthovanadate (including inhibition
f protein tyrosine phosphatases and adenosine triphos-
hatases [31–33]), these data do not constitute proof of a
ause-and-effect relationship. Indeed, definitive resolution
f this concept is hampered by the current lack of pharma-
ological and molecular agents capable of selectively target-
ng MKPs (34). In addition, our results do not exclude the
ossibility that age-related alterations in other signaling
olecules (including, for example, attenuated expression of
TAT 3 [9]) may contribute to the failure of stuttered reflow
o limit infarct size in hearts from aging mice. Nonetheless, our
esults provide novel evidence that 2-year-old mouse hearts are
efractory to infarct size reduction with post-conditioning,
ossibly because of a deficit in ERK phosphorylation caused
n part by an age-associated increase in MKP-1.
eprint requests and correspondence: Dr. Karin Przyklenk,
ardiovascular Research Institute, Wayne State University School
f Medicine, 421 East Canfield Avenue, Room 1107.4, Detroit,
ichigan 48201. E-mail: kprzykle@med.wayne.edu.
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